Résultats de la recherche
10
Tout
Mama’s Creations to Present at Upcoming Investor Conferences
11 mars 2025 08h31 HE
|
Mama’s Creations, Inc.
Management to Discuss Near-Term Revenue Growth and Margin Expansion Expectations Company Continues to Benefit from Robust Operating Position in Current Economic Climate, Benefitting from Fixed Price...
Immunocore to present at upcoming investor conferences
03 mars 2025 07h00 HE
|
Immunocore Holdings plc
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, 03 March 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology...
ITM to Present at Raymond James Private Biotech Symposium
18 févr. 2025 05h00 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich, February 18, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in the Raymond James Private Biotech...
ITM to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
07 févr. 2025 08h00 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich, February 7, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in Oppenheimer’s 35th Annual Healthcare...
Chemomab Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
03 févr. 2025 07h00 HE
|
Chemomab Therapeutics
Chemomab will present at the Oppenheimer Heathcare Life Sciences Conference on Feb 11 at 8 am ET and participate in 1x1 investor meetings.
HydroGraph to Participate in January Investor Conferences
14 janv. 2025 07h00 HE
|
Hydrograph Clean Power Inc.
VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGCPF) (the “Company” or “HydroGraph”) a sustainable commercial manufacturer of pristine...
ITM to Present at the 43rd Annual J.P. Morgan Healthcare Conference
13 déc. 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich, Germany, December 13, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that its Chief Executive Officer, Dr. Andrew...
Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit
03 déc. 2024 07h00 HE
|
Chemomab Therapeutics
Chemomab management is participating in the Oppenheimer Movers in Rare Disease Summit on Dec 13, 2024 at the Westin Grand Central in NYC.
AvePoint to Participate in Upcoming Investor Conferences
11 nov. 2024 09h00 HE
|
AvePoint, Inc.
JERSEY CITY, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in robust data management and data governance, today announced that members of the Company’s executive...
ITM to Participate in Upcoming Investor Conferences
11 nov. 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich, November 11, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry investor...